Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd (JSTL) last reported results for the quarter ended Jun 2026, with sales of ₹18.28 crore and net profit of ₹0.87 crore. The stock last traded at ₹85, a market capitalisation of ₹171 crore, on a P/E of 49.0. Over the past 52 weeks the stock has ranged between ₹37 and ₹93.9. Figures are as of 6 Oct 2026 and are not real time.
Jeevan Scientific Technology Ltd share price and key metrics
- Current price
- ₹85
- Market cap
- ₹171 cr
- Stock P/E
- 49.0
- Book value
- ₹36.1
- ROE
- 1.89%
- ROCE
- 5.01%
- Dividend yield
- 0.00%
- 52w high / low
- 93.9/37.0
Metrics as of 6 Oct 2026. Not real time.
Track Jeevan Scientific Technology Ltd
Cruxal reads every Jeevan Scientific Technology Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Jeevan Scientific Technology Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 6%
- 3 Years
- 19%
- TTM
- 66%
- 10 Years
- 45%
- 5 Years
- -37%
- 3 Years
- 33%
- TTM
- 186%
- 10 Years
- 8%
- 5 Years
- -2%
- 3 Years
- 13%
- 1 Year
- 112%
- 10 Years
- 3%
- 5 Years
- 2%
- 3 Years
- 0%
- Last Year
- 2%
Jeevan Scientific Technology Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹18.28 cr, up 107.7% from ₹8.8 cr a year earlier. Net profit turned positive at ₹0.87 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 11.4 | 12.51 | 10.06 | 8.8 | 12.38 | 19.07 | 21.29 | 18.28 |
| Expenses | 8.9 | 10.44 | 10.44 | 10.58 | 10.31 | 13.84 | 17 | 15.33 |
| Operating profit | 2.5 | 2.07 | -0.38 | -1.78 | 2.07 | 5.23 | 4.29 | 2.95 |
| OPM % | 21.93% | 16.55% | -3.78% | -20.23% | 16.72% | 27.43% | 20.15% | 16.14% |
| Other income | 0.16 | 0.23 | 0.15 | 0.33 | 0.2 | 0.14 | 0.29 | 0.17 |
| Interest | 0.45 | 0.43 | 0.55 | 0.54 | 0.55 | 0.54 | 0.41 | 0.44 |
| Depreciation | 1.49 | 1.48 | 1.77 | 1.74 | 1.69 | 1.6 | 1.61 | 1.7 |
| Profit before tax | 0.72 | 0.39 | -2.55 | -3.73 | 0.03 | 3.23 | 2.56 | 0.98 |
| Tax % | 65.28% | 89.74% | -50.59% | -13.67% | 66.67% | 25.70% | 28.52% | 11.22% |
| Net profit | 0.25 | 0.05 | -1.26 | -3.22 | 0.01 | 2.4 | 1.84 | 0.87 |
| EPS (₹) | 0.16 | 0.07 | -0.82 | -1.96 | -0.06 | 0.90 | 0.81 | 0.27 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Jeevan Scientific Technology Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.21 | 20.39 | 26.13 | 23.94 | 46.9 | 67.79 | 36.18 | 39.65 | 46.84 | 61.54 | 71.02 |
| Operating profit | 3.2 | 3.43 | 5.86 | -6.08 | 17.49 | 16.77 | 1.36 | 4.64 | 7.47 | 9.8 | 14.54 |
| OPM % | 17.57% | 16.82% | 22.43% | -25.40% | 37.29% | 24.74% | 3.76% | 11.70% | 15.95% | 15.92% | 20.47% |
| Net profit | 0.9 | 0.11 | 1.11 | -8.59 | 11.74 | 11.94 | -3.07 | -1.33 | 0.05 | 1.03 | 5.12 |
| EPS (₹) | 0.97 | 0.10 | 0.73 | -5.61 | 7.67 | 7.80 | -1.97 | -0.84 | 0.08 | 0.58 | 1.92 |
TTM is the trailing twelve months to the most recent quarter.
Jeevan Scientific Technology Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 9.28 | 11.46 | 15.30 | 15.30 | 15.30 | 15.30 | 15.48 | 15.48 | 15.83 | 19.92 |
| Reserves | 7.60 | 10.55 | 16.53 | 7.92 | 19.72 | 35.28 | 32.71 | 32.95 | 34.11 | 52.02 |
| Borrowings | 8.45 | 18.78 | 18.15 | 17.95 | 10.34 | 12.55 | 10.10 | 13.41 | 20.58 | 21.28 |
| Other liabilities | 5.56 | 8.59 | 11.32 | 12.70 | 20.62 | 14.75 | 7.63 | 6.03 | 7.77 | 13.37 |
| Total liabilities | 30.89 | 49.38 | 61.30 | 53.87 | 65.98 | 77.88 | 65.92 | 67.87 | 78.29 | 106.59 |
| Fixed assets | 16.35 | 28.17 | 32.59 | 30.54 | 27.38 | 19.07 | 24.97 | 26.66 | 34.55 | 36.08 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.90 | 2.81 | 4.71 | 4.71 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.98 |
| Other assets | 14.54 | 21.21 | 28.71 | 23.33 | 38.60 | 58.81 | 39.05 | 38.40 | 39.03 | 62.82 |
| Total assets | 30.89 | 49.38 | 61.30 | 53.87 | 65.98 | 77.88 | 65.92 | 67.87 | 78.29 | 106.59 |
As reported by the company. Total assets equal total liabilities by construction.
Jeevan Scientific Technology Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5.62 | 5.65 | 4.04 | -0.01 | 4.95 | 19.56 | -6.41 | 2.89 | 10.07 | 0.42 |
| Cash from investing | -8.90 | -14.35 | -7.87 | -1.90 | -0.80 | -1.20 | -6.93 | -11.53 | -15.62 | -9.98 |
| Cash from financing | 14.57 | 9.86 | 6.08 | 0.44 | -0.13 | 5.67 | -9.54 | 2.35 | 5.24 | 18.83 |
| Net cash flow | 0.05 | 1.17 | 2.25 | -1.47 | 4.02 | 24.03 | -22.88 | -6.29 | -0.30 | 9.26 |
| Free cash flow | -14.52 | -8.70 | -3.83 | -1.91 | 4.15 | 17.33 | -14.57 | -9.14 | -5.96 | -7.76 |
| CFO / operating profit | -176% | 165% | 69% | 32% | 39% | 153% | -269% | 101% | 135% | 5% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Jeevan Scientific Technology Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 12.69% | 6.75% | 8.22% | -16.39% | 36.77% | 27.58% | -4.34% | -1.03% | 2.80% | 5.01% |
| Debtor days | 227.10 | 291.79 | 205.20 | 104.29 | 112.46 | 40.97 | 117.83 | 113.14 | 124.21 | 122.71 |
| Inventory days | — | — | — | — | — | 72.11 | 105.50 | 104.15 | 155.61 | 226.63 |
| Days payable | — | — | — | — | — | 98.78 | 322.56 | 205.43 | 305.45 | 458.49 |
| Cash conversion cycle | 227.10 | 291.79 | 205.20 | 104.29 | 112.46 | 14.30 | -99.23 | 11.85 | -25.63 | -109.15 |
| Working capital days | 90.60 | 35.44 | -3.07 | -100.78 | 37.36 | 10.18 | 110.67 | 137.35 | 128.19 | 121.41 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Jeevan Scientific Technology Ltd shareholding pattern
Promoters held 30.25% at Jun 2026, down from 38.05% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 38.70% | 37.84% | 38.05% | 38.05% | 38.05% | 38.05% | 30.25% | 30.25% |
| Public | 61.31% | 62.17% | 61.96% | 61.96% | 61.95% | 61.96% | 69.75% | 69.76% |
| No. of shareholders | 5,607 | 5,565 | 5,497 | 5,460 | 5,444 | 5,159 | 5,053 | 4,966 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Jeevan Scientific Technology Ltd corporate filings
- US FDA Inspection of JSTL Concluded; Establishment Inspection Report Received on 30.09.2026Company Updatelow impact
Cruxal's analysis: Jeevan Scientific Technology Ltd received the US FDA Establishment Inspection Report…
Read the full analysis - Closure of trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015.Insider Trading / SASTlow impact
- Jeevan Scientific Technology Limited Announces Successful Conclusion of 28th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Jeevan Scientific Technology Limited has successfully concluded its 28th Annual General…
Read the full analysis - Jeevan Scientific Technology Limited concludes 28th Annual General Meeting with all resolutions passedAGM/EGMlow impact
Cruxal's analysis: Jeevan Scientific Technology Limited has successfully concluded its 28th Annual General…
Read the full analysis - Jeevan Scientific Technology Ltd publishes mandatory newspaper advertisement for Regulation 30 disclosureCompany Updatelow impact
Cruxal's analysis: Jeevan Scientific Technology Ltd has released a newspaper advertisement in compliance…
Read the full analysis - Jeevan Scientific Technology Ltd releases 28th Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Jeevan Scientific Technology Ltd has filed its 28th Annual Report for the financial year…
Read the full analysis - Jeevan Scientific Technology Limited Announces 28th Annual General Meeting for FY 2025-26AGM/EGMlow impact
Cruxal's analysis: Jeevan Scientific Technology Limited has formally submitted its 28th Annual Report for…
Read the full analysis - Jeevan Scientific Technology Ltd files statement on deviation or variation of funds under Regulation 32Company Updatelow impact
Cruxal's analysis: The company has submitted a statement regarding the deviation or variation in the…
Read the full analysis - Jeevan Scientific Technology Reports Q1 FY27 Financials and Announces Board Reappointments and AGM ScheduleBoard Meetinghigh impact
Cruxal's analysis: Jeevan Scientific Technology Limited reported standalone revenue of 16.93 crore for the…
Read the full analysis - Jeevan Scientific Technology Limited schedules Board Meeting for August 13, 2026, to approve Q1 FY2027 financial results and AGM agendaBoard Meetinglow impact
Cruxal's analysis: Jeevan Scientific Technology Limited has issued a formal intimation regarding a Board…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.